Nu SkinNUS
About: Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
Employees: 11,300
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
125% more call options, than puts
Call options by funds: $486K | Put options by funds: $216K
2% more capital invested
Capital invested by funds: $259M [Q4 2024] → $264M (+$4.27M) [Q1 2025]
3% less repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 69
6% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 33
3% less funds holding
Funds holding: 200 [Q4 2024] → 195 (-5) [Q1 2025]
2.69% less ownership
Funds ownership: 75.75% [Q4 2024] → 73.06% (-2.69%) [Q1 2025]
Research analyst outlook
We haven’t received any recent analyst ratings for NUS.
Financial journalist opinion









